Skip to content
  • Sunday, 26 July 2026
  • 4:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Advanced Materials Science

Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition

Nila Kartika Wati Jul 25, 2026 0

The global plastic crisis has reached a critical juncture, with production levels exceeding 400 million tonnes annually and a significant…

Read More
Pharmaceutical R&D

Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics

Teuku Ryan Jun 30, 2026 0

In a significant development poised to reshape the landscape of immunology therapeutics, New Jersey-based Talawar Therapeutics has officially merged with…

Read More
Pharmaceutical R&D

Sobi Receives Complete Response Letter from FDA for Investigational Gout Therapy NASP, Focus on Manufacturing Deficiencies

Teuku Ryan Jun 30, 2026 0

Swedish Orphan Biovitrum (Sobi) has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) concerning…

Read More
Molecular & Cell Biology

The Complete Wiring Diagram of a Fruit Fly’s Central Nervous System Achieved by International Research Team

Angie Faith Jun 14, 2026 0

In a groundbreaking achievement poised to redefine our understanding of neural circuitry and behavior, an international consortium of scientists, spearheaded…

Read More
Advanced Materials Science

New Ultrafast Imaging Technique CST-CMFI Captures Complete Evolution of Brightness and Internal Structure in Single Measurement

Nila Kartika Wati May 17, 2026 0

The landscape of modern physics and materials science has long been constrained by the fundamental speed of observation. While human…

Read More
Pharmaceutical R&D

FDA Issues Complete Response Letter to Replimune’s RP1 for Advanced Melanoma

Teuku Ryan Apr 14, 2026 0

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Replimune Group’s Biologics License Application…

Read More
Researchers at the Indian Institute of Science Observe Perfect Quantum Fluid in Graphene Breaking Fundamental Laws of PhysicsScientists Identify the Middle Meningeal Artery as a Critical Control Point for Human Brain Waste ClearanceTWiV 1289: Building a Better Hepatitis B TrapBreakthrough Research Reveals Lacunar Stroke Origins Linked to Artery Widening Rather Than Conventional Fatty Plaque Accumulation
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ